GrantRegister

Federal Agency · National Institutes of Health

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

Last updated: November 6, 2026

Posted May 4, 2026

Amount
Up to $500K
Deadline
July 5, 2029 · 971 days remaining
Where
Nationwide
Status
Open

This Notice of Funding Opportunity (NOFO) encourages collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical, or translational science.

This NOFO will support clinical trials that test functionality or validate performance in the chosen setting. This NOFO is not intended to support conventional clinical trials that lack translation as the primary motivation. Applications that propose phase III clinical trials in any area of research are not sought by and will not be supported through this NOFO. This NOFO does not support commercial production.

Focus area

  • Funded by NIH

NAICS: 541714, 621111, 621112, 622

Award details

Awards of up to $500K. Applications close on July 5, 2029 (971 days remaining).

Categories

Not categorized

Grants.gov ↗·Last verified November 6, 2026

Similar grants

GrantRegister provides information, not advice. Eligibility requirements and deadlines are set by the funder and can change without notice. Confirm eligibility, deadlines, and requirements with National Institutes of Health before applying.